UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Case Report: The Conundrum of What to Pick? Antibiotic Susceptibility Variability in Burkholderia cenocepacia in Cystic Fibrosis: Implications for Antibiotic Susceptibility Testing and Treatment

British journal of biomedical science, 2024-06, Vol.81, p.12749

2024

Volltextzugriff (PDF)

Incidence and Risk Factors for Pulmonary Exacerbation Treatment Failures in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa

Chest, 2012-02, Vol.141 (2), p.485-493

2012

Volltextzugriff (PDF)

Delafloxacin––A novel fluoroquinolone for the treatment of ciprofloxacin‐resistant Pseudomonas aeruginosa in patients with cystic fibrosis

The clinical respiratory journal, 2021-01, Vol.15 (1), p.116-120

2021

Volltextzugriff (PDF)

In vitro activity of seven hospital biocides against Mycobacterium abscessus : Implications for patients with cystic fibrosis

International journal of mycobacteriology, 2018-01, Vol.7 (1), p.45

2018

Volltextzugriff (PDF)

Infection dynamics of Stenotrophomonas maltophilia in patients with cystic fibrosis

The Journal of infection, 2023-06, Vol.86 (6), p.626-628

2023

Volltextzugriff (PDF)

Infection Dynamics of Aspergillus fumigatus in Adults with Cystic Fibrosis (CF)

Mycopathologia (1975), 2023-10, Vol.188 (5), p.699-704

2023

Volltextzugriff (PDF)

Carriage of Neisseria meningitidis (meningococci) in the sputum of people with cystic fibrosis (CF): occupational health risks and mitigating interventions for physiotherapists

Physiotherapy, 2024-09, Vol.124, p.101-105

2024

Volltextzugriff (PDF)

A doggy tale: Risk of zoonotic infection with Bordetella bronchiseptica for cystic fibrosis (CF) patients from live licenced bacterial veterinary vaccines for cats and dogs

Journal of clinical pharmacy and therapeutics, 2022-02, Vol.47 (2), p.139-145

2022

Volltextzugriff (PDF)

Does Bordetella pertussis vaccine offer any cross‐protection against Bordetella bronchiseptica? Implications for pet owners with cystic fibrosis

Journal of clinical pharmacy and therapeutics, 2021-10, Vol.46 (5), p.1194-1198

2021

Volltextzugriff (PDF)

New kennel cough vaccine protects vulnerable owners too

Veterinary record, 2021-07, Vol.189 (2), p.78-79

2021

Volltextzugriff (PDF)

Nebulizer Cleaning Practices and Adherence to Nebulized Therapies in People With Cystic Fibrosis When Traveling

Respiratory care, 2022-09, Vol.67 (9), p.1161-1167

2022

Volltextzugriff (PDF)

MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis

ERJ open research, 2016-01, Vol.2 (1), p.64

2016

Volltextzugriff (PDF)

Attitudes to cross infection, nebuliser hygiene and antimicrobial resistance in people with cystic fibrosis: Results of an international survey

Infection, disease & health, 2024-04

2024

Volltextzugriff (PDF)

The virtual CF clinic: Implications for sputum microbiology

Journal of cystic fibrosis, 2021-07, Vol.20 (4), p.699-701

2021

Volltextzugriff (PDF)

The Microbiology of Non-aeruginosa Pseudomonas Isolated From Adults With Cystic Fibrosis: Criteria to Help Determine the Clinical Significance of Non-aeruginosa Pseudomonas in CF Lung Pathology

British journal of biomedical science, 2022-06, Vol.79, p.10468-10468

2022

Volltextzugriff (PDF)

Time-to-first-isolation of methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis (CF): An underutilised metric in infection control?

Infection, disease & health, 2023-11, Vol.28 (4), p.265-270

2023

Volltextzugriff (PDF)

Cystic fibrosis: Infection prevention & control recommendations for universities, colleges and institutes of further and higher education - A practical guide

Infection, disease & health, 2023-05, Vol.28 (2), p.115-129

2023

Volltextzugriff (PDF)

CONCERNS FOR PEOPLE WITH CYSTIC FIBROSIS (PWCF) WHEN TRAVELLING PRE COVID-19

The Ulster medical journal, 2022-01, Vol.91 (1), p.53-55

2022

Volltextzugriff (PDF)

"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis

Journal of clinical microbiology, 2018-09, Vol.56 (9)

2018

Volltextzugriff (PDF)

Comparison of susceptibility of cystic-fibrosis-related and non-cystic-fibrosis-related Pseudomonas aeruginosa to chlorine-based disinfecting solutions: implications for infection prevention and ward disinfection

Journal of medical microbiology, 2014-09, Vol.63 (9), p.1214-1219

2014

Volltextzugriff (PDF)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)

The Ulster medical journal, 2020-01, Vol.89 (1), p.38-39

2020

Volltextzugriff (PDF)

Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis

Journal of antimicrobial chemotherapy, 2011-03, Vol.66 (3), p.476-486

2011

Volltextzugriff (PDF)

Who's at The Door? - Surface Contamination of Door Frames in a Single-Bedded In-Patient Adult Cystic Fibrosis (CF) Unit

The Ulster medical journal, 2020-01, Vol.89 (1), p.17-20

2020

Volltextzugriff (PDF)

Survival dynamics of cystic fibrosis-related Gram-negative bacterial pathogens (Pseudomonas aeruginosa and Burkholderia cenocepacia) in Dead Sea and Atlantic Ocean waters

Journal of water and health, 2015-09, Vol.13 (3), p.773-776

2015

Volltextzugriff (PDF)

Do veterinary antibiotics have efficacy against highly resistant Gram-negative pathogens from patients with cystic fibrosis?

International journal of antimicrobial agents, 2015-01, Vol.45 (1), p.93-95

2015

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Cystic Fibrosis
(19)
Humans
(19)
Microbiology
(9)
Adult
(8)
Cystic Fibrosis - Microbiology
(7)
Cystic Fibrosis - Complications
(6)
Pseudomonas Aeruginosa
(6)
Respiratory System
(6)
Anti-Bacterial Agents - Pharmacology
(5)
Female
(5)
Infectious Diseases
(5)
Male
(5)
Microbial Sensitivity Tests
(5)
Cross Infection
(4)
Infection Control
(4)
Pharmacology & Pharmacy
(4)
Pulmonary/respiratory
(4)
Anti-Bacterial Agents - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Case Report: The Conundrum of What to Pick? Antibiotic Susceptibility Variability in Burkholderia cenocepacia in Cystic Fibrosis: Implications for Antibiotic Susceptibility Testing and Treatment

Incidence and Risk Factors for Pulmonary Exacerbation Treatment Failures in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa

Delafloxacin––A novel fluoroquinolone for the treatment of ciprofloxacin‐resistant Pseudomonas aeruginosa in patients with cystic fibrosis

In vitro activity of seven hospital biocides against Mycobacterium abscessus : Implications for patients with cystic fibrosis

Infection dynamics of Stenotrophomonas maltophilia in patients with cystic fibrosis

Infection Dynamics of Aspergillus fumigatus in Adults with Cystic Fibrosis (CF)

Carriage of Neisseria meningitidis (meningococci) in the sputum of people with cystic fibrosis (CF): occupational health risks and mitigating interventions for physiotherapists

A doggy tale: Risk of zoonotic infection with Bordetella bronchiseptica for cystic fibrosis (CF) patients from live licenced bacterial veterinary vaccines for cats and dogs

Does Bordetella pertussis vaccine offer any cross‐protection against Bordetella bronchiseptica? Implications for pet owners with cystic fibrosis

New kennel cough vaccine protects vulnerable owners too

Nebulizer Cleaning Practices and Adherence to Nebulized Therapies in People With Cystic Fibrosis When Traveling

MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis

Attitudes to cross infection, nebuliser hygiene and antimicrobial resistance in people with cystic fibrosis: Results of an international survey

The virtual CF clinic: Implications for sputum microbiology

The Microbiology of Non-aeruginosa Pseudomonas Isolated From Adults With Cystic Fibrosis: Criteria to Help Determine the Clinical Significance of Non-aeruginosa Pseudomonas in CF Lung Pathology

Time-to-first-isolation of methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis (CF): An underutilised metric in infection control?

Cystic fibrosis: Infection prevention & control recommendations for universities, colleges and institutes of further and higher education - A practical guide

CONCERNS FOR PEOPLE WITH CYSTIC FIBROSIS (PWCF) WHEN TRAVELLING PRE COVID-19

"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis

Comparison of susceptibility of cystic-fibrosis-related and non-cystic-fibrosis-related Pseudomonas aeruginosa to chlorine-based disinfecting solutions: implications for infection prevention and ward disinfection

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)

Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis

Who's at The Door? - Surface Contamination of Door Frames in a Single-Bedded In-Patient Adult Cystic Fibrosis (CF) Unit

Survival dynamics of cystic fibrosis-related Gram-negative bacterial pathogens (Pseudomonas aeruginosa and Burkholderia cenocepacia) in Dead Sea and Atlantic Ocean waters

Do veterinary antibiotics have efficacy against highly resistant Gram-negative pathogens from patients with cystic fibrosis?

Suchergebnisse filtern